secwatch.observer — SEC 8-K summary
======================================

Issuer:     IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
CIK:        0001425205
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001104659-25-085650
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iovance posts updated corporate presentation for August 2025; no specific details disclosed
--------------------------------------------------------------------------------

- Company filed an 8-K announcing a revised corporate presentation dated August 2025.
- Presentation is used at healthcare conferences and for discussions with analysts and stockholders.
- Exhibit 99.1 incorporated by reference but full content not provided in this filing excerpt.
- No financial or clinical milestones were explicitly stated in the filing body.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425205/000110465925085650/0001104659-25-085650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425205/000110465925085650/tm2524604d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-085650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer